Safety and Efficacy of a Topical Otic Formulation in the Treatment of Acute Otitis Media With Otorrhea Through Tympanostomy Tubes (AOMT).

Trial Profile

Safety and Efficacy of a Topical Otic Formulation in the Treatment of Acute Otitis Media With Otorrhea Through Tympanostomy Tubes (AOMT).

Completed
Phase of Trial: Phase III

Latest Information Update: 29 Nov 2012

At a glance

  • Drugs Moxifloxacin (Primary) ; Moxifloxacin/dexamethasone (Primary)
  • Indications Otitis media; Otorrhoea
  • Focus Registrational; Therapeutic Use
  • Sponsors Alcon
  • Most Recent Events

    • 02 Feb 2012 Actual patient number 776 added as reported by ClinicalTrials.gov.
    • 13 May 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 13 May 2009 Actual end date (Jan 2009) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top